These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28267054)

  • 1. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
    Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient insights on features of an effective pharmacogenomics patient portal.
    Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
    Borden BA; Lee SM; Danahey K; Galecki P; Patrick-Miller L; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Kavitt RT; Meltzer DO; Ratain MJ; O'Donnell PH
    Pharmacogenomics J; 2019 Dec; 19(6):528-537. PubMed ID: 30713337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
    McKillip RP; Borden BA; Galecki P; Ham SA; Patrick-Miller L; Hall JP; Hussain S; Danahey K; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Ratain MJ; Meltzer DO; O'Donnell PH
    Clin Pharmacol Ther; 2017 Jul; 102(1):106-114. PubMed ID: 27981566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine from a citizen perspective: a survey of public attitudes towards pharmacogenomics in Flanders.
    Edris A; Callier E; Lahousse L
    BMC Med Genomics; 2022 Sep; 15(Suppl 3):193. PubMed ID: 36096833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding pharmacogenomic testing and its role in medicine prescribing.
    Youssef E; Buck J; Wright DJ
    Nurs Stand; 2020 Jul; 35(7):55-60. PubMed ID: 32524796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial.
    Truong TM; Apfelbaum JL; Danahey K; Schierer E; Ludwig J; George D; House L; Karrison T; Shahul S; Anitescu M; Choksi A; Hartman S; Knoebel RW; van Wijk XMR; Yeo KJ; Meltzer DO; Ratain MJ; O'Donnell PH
    Anesth Analg; 2022 Nov; 135(5):929-940. PubMed ID: 35213469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.
    Rosenman MB; Decker B; Levy KD; Holmes AM; Pratt VM; Eadon MT
    Value Health; 2017 Jan; 20(1):54-59. PubMed ID: 28212969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals.
    Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL
    Intern Med J; 2022 Jul; 52(7):1135-1143. PubMed ID: 35191159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.
    Wright AJ; Sutton S; Armstrong D; Aveyard P; Kinmonth AL; Marteau TM
    Transl Behav Med; 2018 Jan; 8(1):18-28. PubMed ID: 29385578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the barriers and enablers of pharmacogenomic testing in primary care: a qualitative systematic review with meta-aggregation synthesis.
    Qureshi S; Latif A; Condon L; Akyea RK; Kai J; Qureshi N
    Pharmacogenomics; 2022 Jan; 23(2):135-154. PubMed ID: 34911350
    [No Abstract]   [Full Text] [Related]  

  • 17. Does Preoperative Pharmacogenomic Testing of Patients Undergoing TKA Improve Postoperative Pain? A Randomized Trial.
    Kraus MB; Bingham JS; Kekic A; Erickson C; Grilli CB; Seamans DP; Upjohn DP; Hentz JG; Clarke HD; Spangehl MJ
    Clin Orthop Relat Res; 2024 Feb; 482(2):291-300. PubMed ID: 37594401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.
    Reid P; Danahey K; Lopez Velazquez M; Ratain MJ; O'Donnell PH
    Clin Exp Rheumatol; 2021; 39(6):1385-1393. PubMed ID: 33506753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
    Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
    Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.